Celiac Test: Which Blood Tests Detect Celiac Disease (and Why Timing Matters)

The Scale of Missed Celiac Disease

The Celiac Disease Panel screens for antibodies that develop when people with celiac disease consume gluten. This autoimmune condition affects approximately 1.4% of the global population according to recent meta-analysis data, but diagnosis rates vary dramatically by geography and awareness levels.

In the United States, only about 1 in 4 people with celiac disease have been diagnosed. The remainder live with symptoms they may attribute to irritable bowel syndrome, food intolerances, stress, or simply normal aging. Many cycle through specialists trying to understand why they feel unwell despite normal routine blood work and imaging studies.

The condition affects all ethnic groups but shows some geographic clustering. Prevalence rates are highest in populations with Northern European ancestry, reaching 2-3% in some Scandinavian countries. However, celiac disease occurs worldwide, including in populations once thought to be protected, such as those in the Middle East, Asia, and Africa. The global increase in wheat consumption may be revealing previously hidden cases.

Understanding Celiac Serology: Which Tests Work Best

Modern celiac testing relies primarily on tissue transglutaminase antibodies, specifically the IgA class (tTG-IgA). This enzyme plays a central role in celiac pathophysiology by modifying gliadin peptides, creating new epitopes that trigger immune responses in genetically susceptible individuals.

A comprehensive review of celiac serology found that tTG-IgA demonstrates 91-97% sensitivity and 96-100% specificity for celiac disease when intestinal damage is present. This makes it the single best screening test for most patients. The test performs well across different age groups and ethnic populations, though sensitivity may be slightly lower in very young children.

Endomysial antibodies (EMA-IgA) show similar accuracy but are more expensive and technically demanding to perform. Deamidated gliadin peptide antibodies (DGP-IgA and DGP-IgG) add value in specific situations, particularly in young children under age 2, where tTG-IgA may be less reliable. The combination approach catches edge cases that single tests might miss.

The IgA Deficiency Problem

All the most accurate celiac tests measure IgA antibodies, but 2-3% of people have selective IgA deficiency, a condition that's 10-15 times more common in people with celiac disease than in the general population. These individuals cannot produce IgA antibodies, so tTG-IgA and EMA-IgA tests will be falsely negative even in the presence of severe intestinal damage.

This is why comprehensive celiac panels include total IgA measurement alongside the antibody tests. If total IgA is low or undetectable, IgG-based tests (like DGP-IgG or tTG-IgG) become the primary screening tools. Missing IgA deficiency leads to missed celiac disease diagnoses, particularly in people who have been told their tests were normal despite persistent symptoms.

Some gastroenterologists now recommend checking total IgA routinely in anyone being tested for celiac disease. The additional cost is minimal, but the information prevents false reassurance in IgA-deficient patients who might otherwise be told they don't have celiac disease based on negative IgA-based tests.

Why Gluten-Free Diets Invalidate Testing

Celiac antibodies develop in response to gluten exposure. Remove gluten from the diet, and antibody levels gradually decline toward normal, even in people with celiac disease. This creates a major diagnostic challenge: people often try gluten-free diets to see if they feel better, inadvertently making subsequent celiac testing unreliable.

The American College of Gastroenterology guidelines emphasize that patients must be consuming gluten-containing foods during testing. Most experts recommend eating the equivalent of 1-2 slices of bread daily for at least 2-8 weeks before testing, though some antibodies may take months to normalize after gluten reintroduction.

This creates a difficult situation for people who feel dramatically better on a gluten-free diet. Gluten challenge protocols exist but require medical supervision and can cause significant symptoms. Some people choose to continue the gluten-free diet based on clinical response rather than pursuing formal testing, but this approach makes it impossible to monitor for complications or provide appropriate family counseling.

Genetic Testing: When HLA Typing Helps

Nearly all people with celiac disease (95-97%) carry specific HLA genetic variants: HLA-DQ2 or HLA-DQ8. These genes are necessary but not sufficient for celiac disease development. About 30-40% of the general population carries these variants, but only a small fraction develops celiac disease.

HLA testing serves as a powerful negative predictor. People who lack both HLA-DQ2 and HLA-DQ8 have essentially zero risk of developing celiac disease. This makes genetic testing useful in specific situations: ruling out celiac disease in people already on gluten-free diets, evaluating family members, and assessing individuals with negative serology but high clinical suspicion.

Genetic testing doesn't require gluten consumption and remains stable throughout life. For people who have been gluten-free for extended periods and don't want to undergo gluten challenge, negative HLA typing can rule out celiac disease definitively. Positive HLA typing doesn't diagnose celiac disease but indicates that the person has the genetic susceptibility.

Pediatric Testing: Different Rules for Children

European pediatric guidelines have revolutionized celiac diagnosis in children by allowing biopsy-free diagnosis in specific circumstances. Children with symptoms suggestive of celiac disease, tTG-IgA levels more than 10 times the upper limit of normal, positive EMA antibodies, and positive HLA genetics can be diagnosed without intestinal biopsy.

This approach recognizes that very high antibody levels are virtually diagnostic of celiac disease and spare symptomatic children from invasive procedures. The criteria are strict: all elements must be present, and the tTG-IgA must be dramatically elevated, not just above the reference range.

Adult guidelines remain more conservative, still requiring biopsy confirmation in most cases. However, the pediatric experience suggests that very high antibody levels in symptomatic patients are rarely falsely positive. Some adult gastroenterologists now use similar approaches in carefully selected cases, particularly when biopsy would be technically difficult or risky.

Family Screening: Who Should Be Tested

First-degree relatives (parents, siblings, children) of people with celiac disease have a 10-15% risk of developing the condition themselves, roughly 10 times higher than the general population risk. Many medical societies now recommend screening first-degree relatives, even if they feel completely healthy.

Silent celiac disease (positive serology and intestinal damage without obvious symptoms) occurs in about 20-30% of diagnosed relatives. These individuals may feel well but still face long-term complications including osteoporosis, infertility, and increased cancer risk if left untreated.

Screening recommendations vary by organization, but most suggest testing first-degree relatives at least once, with consideration for repeat testing every few years since celiac disease can develop at any age. Children of parents with celiac disease should be tested if they develop any suggestive symptoms, growth problems, or other autoimmune conditions.

Interpreting Results: When Numbers Matter

Celiac serology isn't simply positive or negative. Antibody levels correlate roughly with the degree of intestinal damage, and very high levels are more specific for celiac disease than borderline elevations. Most labs report results as multiples of the upper limit of normal rather than absolute values.

tTG-IgA levels more than 3 times the upper limit of normal are highly specific for celiac disease in symptomatic patients. Levels 1-3 times the upper limit may represent early celiac disease, other autoimmune conditions, or occasionally false positives. Borderline results often require additional testing with EMA or consideration of intestinal biopsy.

If you have digestive symptoms, fatigue, joint pain, skin problems, or neurological symptoms that remain unexplained, celiac testing provides definitive answers. The key is proper preparation: ensure adequate gluten intake before testing, understand that genetic testing can rule out but not diagnose celiac disease, and recognize that borderline results may require additional evaluation. Early diagnosis prevents long-term complications and can dramatically improve quality of life.